Alp Bio - NervNow™

InFunding & Startups, News

ALP Bio Raises €1.9M for AI Drug Discovery Platform

Swiss biotech ALP Bio AG has raised €1.9M in pre-seed funding to predict immunogenicity risks earlier in biologics using AI and human immune organoids.

ByNN Desk
Onmai 4, 2026

Stay updated with NervNow Weekly

Subscribe now

ALP Bio Raises €1.9M for AI Drug Discovery Platform

Exaforce Hits $725M Valuation With $125M Bet on Autonomous Security

Cybersecurity Startup Prikus Raises $2.5 Million to Build AI Security Platform

HrdWyr Raises $13 Mn in Series A to Build AI-Native Chips for Edge Devices

Google DeepMind’s Isomorphic Labs Just Raised a Massive $2.1 Billion

DronaHQ Unveils New No-Code Platform to Build Enterprise AI Agents

Dessn Bags $6M to Help Designers Collaborate Directly in Codebases

Vapi Hits $500M Valuation Following $50M AI Funding Round

Helsing Could Become Europe’s Most Valuable Private Defense Tech Startup

SCIKIQ Bags $1.5M in Seed Funding Led by Triton to Fuel Enterprise AI Growth

Flo Mobility Wins Big With $2.5 Million to Transform Construction

Stay updated with NervNow Weekly

Populare acum

Stay updated with NervNow Weekly